guest
2023-12-03

LabKey Studies
Data Generator
Visualizations
Timeline
Steve Wiki
Enter Sample Manager
steve test
SteveTestHTML Page
Test Wiki
Study Timeline
Contact Us
Evaluating LabKey?
Explore this Study
Banner
Trial - make this frameless
Contact - make this frameless
Help - make this frameless

LabKey Studies

This research data portal highlights key features of LabKey's study module, which provides everything researchers need to manage their clinical and experimental data, including:

Quality control and data curation
Alignment of heterogeneous datasets, such as clinical, experimental, and sample data
Visualizations, dashboards, and live reports
Security and data de-identification for publishing
and much more

Data Quality Control

Customize your own quality control states to apply to your data. Built-in quality control reports provide an overview of the status of all datasets and help you identify which data is in need of review and approval.

Alignment

Link all your datasets into an integrated whole for analysis and presentation. Experimental, demographic, and clinical datasets are automatically connected upon import to LabKey. Data from disparate sites can be easily connected using web-based data entry tools and drag-and-drop file upload.

Visualization & Analysis

Visualize, analyze and display integrated study data using a range of built-in plotting and reporting tools available in LabKey Server. Use LabKey's built-in support for R to present live reports within a LabKey Server study.

Publication and Security

Provide direct access to study results using LabKey Server's data publishing tools. Provide access to a subset of data to a selected audience, such as collaborators or the general public. De-identify Protected Health Information (PHI) by randomizing participant IDs, shifting dates, and masking clinic names in published datasets. Or hold back specified columns of data from publication. These data de-identification features help support HIPAA compliant data sharing.

Case Studies

See LabKey's study management tools in action.

Case Study #1: ITN Trial Share- A research data portal for both operational data management and publication of data from clinical trials.
Case Study #2: LabKey Open Research Portal- A portal supporting multiple teams investigating emerging viruses such as Zika and Covid-19 (Coronavirus).

LabKey Studies: Learn More

Evaluating LabKey?

Contact Us

Request a Demo

Data Generator

Datasets in this study was created by random number generators, which are here:

curl "https://api.mockaroo.com/api/31e33d80?count=12&key=a63ea580" > "Demographics.tsv"
curl "https://api.mockaroo.com/api/692e49d0?count=12&key=a63ea580" > "MedicalHistory.tsv"
curl "https://api.mockaroo.com/api/4c23cd90?count=300&key=a63ea580" > "PhysicalExam.tsv"
curl "https://api.mockaroo.com/api/0ab7e180?count=300&key=a63ea580" > "LabResults.tsv"
curl "https://api.mockaroo.com/api/79c179c0?count=300&key=a63ea580" > "ViralLoadPCR.tsv"
curl "https://api.mockaroo.com/api/e12160e0?count=300&key=a63ea580" > "ViralLoadNASBA.tsv"
curl "https://api.mockaroo.com/api/a64ffae0?count=3000&key=a63ea580" > "SpecimenRepository.txt"

Visualizations

Timeline

Steve Wiki

Here is my amazing report!

Enter Sample Manager

View study samples in the

Sample Manager Application

steve test

SteveTestHTML Page

Test Wiki

Study Timeline

Contact Us

Contact Us

Evaluating LabKey?

Contact Us

Request a Demo

Explore this Study

The example research data portal below demostrates one way to present your study findings to colleages and the general public. It highlights key features of LabKey's study module, including: quality control, data curation, data alignment and integration, visualizations, dashboards, and live reports.

HIV Disease Progression: A Comparison of ARV Treatment Regimens

This study compares various anti-retroviral (ARVs) treatment regimens by monitoring HIV-1 disease progression in 12 participants. Disease metrics include: viral load, CD4 counts, and white blood cell counts. 2 different methods of measuring viral load were used in tandem, PCR and NASBA.

ARV treatment was initiated in the 8th week. Dosage was evaluated every 4 weeks during treatment.

Treatment Regimens

Datasets Collected

Visualizations

Findings

Participants under the ETR Regimen fared better than those under the DRV Regimen. In general, participants under any ARV regimen fared better than those without treatment.

Note that all data presented here is fictional and created by random data generators.

Study Overview